Asia Coma Electrical Stimulation (the ACES Trial)

Sponsor
RenJi Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02645578
Collaborator
All India Institute of Medical Sciences, New Delhi (Other), JSC National Center for Neurosurgery, Republic of Kazakhstan (Other), College of Medical Sciences Teaching Hospital. Nepal (Other)
360
2
23

Study Details

Study Description

Brief Summary

This study is a prospective multicenter randomized controlled trial from Asian countries to compare the effect and safety of right median nerve stimulation versus traditional treatment for comatose patients at the early stage following traumatic brain injury.

Condition or Disease Intervention/Treatment Phase
  • Device: Right median nerve stimulation
Phase 3

Detailed Description

Traumatic brain injury (TBI) is a leading cause of mortality and morbidity and one of the greatest unmet needs in public health. The most severe injury can lead to a poor outcome and prolonged coma of the victims. It is estimated that ten to fifteen percent of the severe TBI patients are discharged in a prolonged coma or a vegetative state. However, no treatment measure to data has been proven robustly to alter the pace of recovery or improve neurological outcome of the comatose patients following TBI.

Although right median nerve electrical stimulation (RMNS) has been used clinically for more than two decades, no strong evidence of efficacy was generated because of the limitations in the past trials including a small sample size or the inappropriate study design. In the present study, a multicenter research network with inclusion of neurotrauma centers from China, India, Nepal and Kazakhstan was established with the aim to validate the efficacy and safety of a promising intervention strategy for traumatic coma at early stage. Since RMNS is a simple, inexpensive, noninvasive technique with a good safety profile, our study will probably add more evidence to the treatment of traumatic coma in Asian countries.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
360 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Asia Coma Electrical Stimulation Trial: an Asian Multicenter Randomized Controlled Trial to Assess the Efficacy and Safety of Right Median Nerve Stimulation for Traumatic Coma
Study Start Date :
Jan 1, 2016
Anticipated Primary Completion Date :
Jun 1, 2017
Anticipated Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: RMNS group

Focus intervention: right median nerve stimulation plus standard management

Device: Right median nerve stimulation
Right median nerve electrical stimulation (RMNS) is administered via a pair of lubricated one-inch square rubber surface electrodes pasted on the volar aspect of the right distal forearm over the median nerve. An electrical neuromuscular stimulator supplied trains of asymmetric biphasic pluses at an amplitude of 20 milliamps with a pulse width of 300 microseconds at 40 Hz for 20 sec/min. The RMNS treatment continues 8 hours per day for two weeks.
Other Names:
  • RMNS
  • No Intervention: Control group

    Standard management

    Outcome Measures

    Primary Outcome Measures

    1. Proportion of patients returning consciousness [Within six months after injury]

      The term "consciousness" is defined when the patient shows objective ability to respond to verbal commands.

    Secondary Outcome Measures

    1. Duration of unconsciousness [Within six months after injury]

      This outcome is defined as the time between trauma and objective recovery of the ability to respond to verbal commands

    2. Adverse events [Within six months post injury]

      The potential adverse events include but not limited to seizures, intracranial bleeding, increased sympathetic activity and so on.

    3. Glasgow Coma Scale (GCS) [28 days post injury]

    4. Coma Recovery Scale-Revised (CRS-R) [six months post injury]

    5. Disability Rating Scale (DRS) [six months post injury]

    6. Full Outline of UnResponsiveness scale(FOUR) [28 days post injury]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • A confirmed history of closed traumatic brain injury 10 days before enrollment

    • A Glasgow coma scale (GCS) score of 4-8 or the motor part less than 5 if the patient received tracheotomy.

    • 18-65 years of age

    Exclusion Criteria:
    • Unstable vital signs

    • Have a history of severe cardiac arrhythmias, implanted pacemaker, as well as seizures

    • Pregnancy

    • No informed consent

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • RenJi Hospital
    • All India Institute of Medical Sciences, New Delhi
    • JSC National Center for Neurosurgery, Republic of Kazakhstan
    • College of Medical Sciences Teaching Hospital. Nepal

    Investigators

    • Study Chair: Jiyao Jiang, RenJi Hospital
    • Study Director: Junfeng Feng, RenJi Hospital
    • Principal Investigator: Guoyi Gao, RenJi Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Guoyi Gao, Associate professor, RenJi Hospital
    ClinicalTrials.gov Identifier:
    NCT02645578
    Other Study ID Numbers:
    • Renjineuro
    First Posted:
    Jan 1, 2016
    Last Update Posted:
    Jan 1, 2016
    Last Verified:
    Dec 1, 2015
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Guoyi Gao, Associate professor, RenJi Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 1, 2016